CPCF settlement: 2019/20 to 2023/24
CPCF settlement: 2019/20 to 2023/24
Following negotiations between PSNC, the Department of Health and Social Care (DHSC) and NHS England and NHS Improvement (NHSE&I), HM Government has agreed to make a five-year investment in community pharmacies. The deal secures pharmacy funding and sets out a clear vision for the expansion of clinical service delivery over the next five years, in line with the NHS Long Term Plan.
The announcement: Funding negotiations result in five-year CPCF deal
The CPCF agreement document: The Community Pharmacy Contractual Framework for 2019/20 to 2023/24: supporting delivery for the NHS Long Term Plan
PSNC’s summary of the agreement document: PSNC Briefing 026/19: A Summary of the Five-Year Deal on the Community Pharmacy Contractual Framework
PSNC answers key questions: PSNC Briefing 027/19: Five-Year CPCF Deal – Frequently Asked Questions
PSNC email series highlighting key actions for contractors: CPCF Checklist emails archive
PSNC had been running free roadshow events across England to explain the context of the new five-year CPCF agreement and what it means for pharmacies. These have come to an end, but contractors can now access a recording of our Digital Roadshow.
This online event followed the same format as the regional roadshow events, with presentations from the PSNC Chief Executive and his team, followed by a Q&A session. It provides an opportunity to explore what the future holds for your pharmacy and to help prepare yourself and your team for that.
About the CPCF
In each section below we have outlined that element of the five-year CPCF agreement in more detail.
Funding and payments
The community pharmacy sector will receive £2.592bn per year from 2019/20 to 2023/24. However, some of the details of how funding will be distributed in the next financial year are still the subject of urgent negotiations with the NHS and Department of Health and Social Care.
Drug Tariff changes: To ensure delivery of the correct amount of funding to contractors in 2019/20, Category M reimbursement prices increased by £15 million a month and the Single Activity Fee (SAF) was increased by 1p to £1.27 per item from August 2019. Learn more about the October 2019 Drug Tariff changes here.
Transitional payments: Monthly payments will be paid to help community pharmacy contractors meet costs associated with changes such as integration into Primary Care Networks (PCNs), preparation for Serious Shortage Protocols (SSPs) and implementation of the Falsified Medicines Directive (FMD). These payments will be linked to dispensing volumes and paid to contractors from October 2019 through to March 2021. Learn more about the agreed levels here.
Establishment Payment: As previously indicated by HM Government, these payments will be phased out by 2020/21.
Pharmacy Access Scheme (PhAS): this will continue with the current criteria and funding (£24 million a year) until a new scheme is introduced in April 2020. Further details of next year’s funding is expected shortly.
PSNC will publish indicative income tables for contractors in due course to help contractors to predict what their income is likely to be over the next financial year.
NHS Community Pharmacist Consultation Service (CPCS)
CPCS is a new Advanced service where patients are referred into community pharmacy by other NHS providers. Commencing October 2019, this service replaces the current NHS Urgent Medicine Supply Advanced Service (NUMSAS) and local pilots of the Digital Minor Illness Referral Service (DMIRS).
Funding for the CPCS includes an initial Transition payment supplement of £900 if claimed by 1st December 2019, or £600 if claimed by 15th January 2020.
Pharmacy Quality Scheme (PQS)
PQS is a new name for the Quality Payments Scheme. The gateway and quality criteria from previous years will change on an annual basis, with some becoming CPCF Terms of Service requirements from April 2020.
Medicines Use Reviews (MURs)
To free up capacity and funding for the CPCS, and also in recognition that NHSE&I does not consider them to offer good value for money, MURs will be phased out over the next two years.
A range of new services will be piloted and introduced over the course of the five years to support the delivery of the NHS Long Term Plan.
CPCF service development grid – a matrix document setting out when each of the agreed CPCF service development pilots may be implemented during the five-year deal
A commitment was made to considering a range of reforms to reimbursement arrangements – step one is running a public consultation.
For external audiences
The PSNC Communications and Public Affairs Team has created the following resources to help in explaining the five-year CPCF to external audiences. These may be particularly useful for LPCs engaging with local healthcare organisations or other stakeholders.
Community pharmacy presentation – a PowerPoint about community pharmacy reflecting changes to the CPCF.
CPCF summary for external stakeholders (Word document, so it can be edited for localisation)
Summary of the Five-Year Pharmacy Deal for general practice teams (Word document, so it can be edited for localisation)
Template letter to GP practices on five-year CPCF – LPCs may wish to ask their LMC to send this letter/email out to local GP practices.
An infographic describing the five-year CPCF settlement – this outlines the journey that community pharmacy will take between now and 2023/24.
Also see our webpage Community Pharmacy: Information for GPs.
If you have a query that isn’t addressed by this webpage, please email firstname.lastname@example.org
This page will be updated as more details and resources become available.